102ND GENERAL ASSEMBLY
State of Illinois
2021 and 2022
HB4987
 
Introduced 1/27/2022, by Rep. Bob Morgan
 
SYNOPSIS AS INTRODUCED:
 

 
410 ILCS 705/55-100 new

     Amends the Cannabis Regulation and Tax Act. Provides that a cannabis business establishment licensed by the Department of Agriculture for cultivating, growing, processing, manufacturing, or infusing cannabis or a cannabis-infused product pursuant to the Cannabis Regulation and Tax Act or the Compassionate Use of Medicinal Cannabis Program Act may use industrial hemp as an ingredient in cannabis or a cannabis-infused product that is offered for sale at a dispensary. Provides that hemp flower may not be sold to a dispensary. Provides that industrial hemp may be procured from a licensed third-party grower or processor from within the State of Illinois or from any other state with a regulated industrial hemp program. Requires all hemp and hemp derivatives obtained by a cannabis business establishment to be obtained from a licensed or registered hemp grower or processor. Provides that a cultivation center that intends to use hemp or a hemp derivative must apply for, and be issued, a Hemp Processor License by the Department. Requires a representative sample of all final products containing industrial hemp or hemp derivatives to undergo specified testing. Contains other provisions. Effective immediately.
  


LRB102 24141 CPF 35353 b

 
 
A BILL FOR
 

  
HB4987LRB102 24141 CPF 35353 b


  
1    AN ACT concerning regulation.
  
 
2    Be it enacted by the People of the State of Illinois,
 
3represented in the General Assembly:
  
 
 
4    Section 5. The Cannabis Regulation and Tax Act is amended  
5by adding Section 55-100 as follows:
 
6    (410 ILCS 705/55-100 new)
7    Sec. 55-100. Hemp in cannabis-infused products.
8    (a) In this Section: 
9    "Hemp" or "industrial hemp" has the same meaning as 
10provided in Section 5 of the Industrial Hemp Act. 
11    (b) A cannabis business establishment licensed by the 
12Department for cultivating, growing, processing, 
13manufacturing, or infusing cannabis or a cannabis-infused 
14product pursuant to this Act or the Compassionate Use of 
15Medicinal Cannabis Program Act may use industrial hemp as an 
16ingredient in cannabis or a cannabis-infused product that is 
17offered for sale at a dispensary. However, hemp flower may not 
18be sold to a dispensary. 
19    (c) Hemp obtained under subsection (b) must be used in 
20extracted form and only in a cannabis-infused product. 
21    (d) Industrial hemp may be procured from a licensed 
22third-party grower or processor from within the State of 
23Illinois or from any other state with a regulated industrial 
 
 
HB4987- 2 -LRB102 24141 CPF 35353 b

1hemp program. 
2    (e) All hemp and hemp derivatives obtained by a cannabis 
3business establishment must be obtained from a licensed or 
4registered hemp grower or processor, regardless of the 
5grower's or processor's home state. A cannabis business 
6establishment that obtains hemp or a hemp derivative must 
7provide a copy of the hemp grower's or processor's license 
8issued by Illinois or another state upon demand of the 
9Department or the Illinois State Police. 
10    (f) A cultivation center that intends to use hemp or a hemp 
11derivative must apply for, and be issued, a Hemp Processor 
12License by the Department. 
13    (g) Industrial hemp flower and biomass may be purchased 
14and extracted by a cultivation center. 
15    (h) A cultivation center may procure or process industrial 
16hemp in the form of distillate or isolate. All processed hemp 
17derivatives must be accompanied by a certificate of analysis 
18showing potency levels for delta-9 tetrahydrocannabinol (THC), 
19THCa, CBD, and CBDa. 
20    (i) The delta-9 tetrahydrocannabinol (THC) contained in 
21hemp or a hemp derivative procured or processed under 
22subsection (h) may not be concentrated above the allowable 
230.3% threshold. 
24    (j) Hemp or hemp derivatives may not be used to 
25concentrate or to synthesize delta-9 tetrahydrocannabinol 
26(THC), unless the concentration or synthesis of the hemp or 
 
 
HB4987- 3 -LRB102 24141 CPF 35353 b

1hemp derivative is performed at a cultivation center, craft 
2grower, or infuser. 
3    (k) A representative sample of all final products 
4containing industrial hemp or hemp derivatives must undergo 
5testing pursuant to the Compassionate Use of Medical Cannabis 
6Act, the Cannabis Regulation and Tax Act, and any applicable 
7administrative rules. 
 
 
8    Section 99. Effective date. This Act takes effect upon 
9becoming law.